E

A tale of two cities – a look at two small immunotherapy biotechs

Going beyond anti-PD1 checkpoint blockade is important if we want to help more people respond to cancer immunotherapy

January 14, 2019
E

TKIs are still alive and kicking!

Drugging the undruggable with creative approaches to molecule development

January 9, 2019
E

JPM19 Day 3 Highlights

Commentary on some up and coming biotechs in the oncology space

January 9, 2019
E

JPM19 Highlights from Day 2

Insights and commentary from the second day at #JPM19

January 8, 2019
E

JPM19 Highlights from Day 1

Insights and commentary from the first day of JPM19

January 7, 2019